Plain-English translation of NCT06623994 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a program called BEACON that aims to help people with epilepsy in Kenya get better care and stick with their treatment. Some participants will receive standard epilepsy care at a health facility, while others will receive care from specially trained staff who will also send appointment reminders and help track their progress. The study will compare how well each approach works for helping people stay on their medications and manage their seizures.
Many people with epilepsy in Kenya don't take their medications regularly or stay connected to care, which leads to more seizures, injuries, and serious health problems. This trial is testing whether having more trained staff, better record systems, and appointment reminders can help people stick with treatment and live healthier lives.
You likely qualify if…
You likely don't qualify if…
You will be randomly placed into either the standard care group or the enhanced BEACON care group. Both groups will have clinic visits at baseline and then at 6, 12, and 18 months to check on your health and seizures. If you are in the BEACON group, you will receive care from trained clinicians and nurses, and you will receive text or phone reminders two days before your appointments to help you remember to come in. The study team will also help keep track of your appointments to make sure you don't get lost to follow-up.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Kenya
Sponsor
Indiana University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment target
~650 participants
Started
August 2025
Primary completion
February 2028
Age range
12 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jane von Gaudecker, PhD
Indiana University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.